insights_auto
Why is INO down २.०५%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.४३
arrow_downward
-२.०५%(-०.०३०) 1D
US$ १.४२
arrow_downward
-०.७०% (-०.०१००)todayPre-market
Closed: नोभेम्बर १३, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.४४
High
US$ १.४८
Low
US$ १.३९
Mkt. cap
२६.७८ करोड
Avg. vol.
१.९३ करोड
Volume
१७.२८ हजार
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ ०.८०
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
Open
US$ १.४४
High
US$ १.४८
Low
US$ १.३९
Mkt. cap
२६.७८ करोड
Avg. vol.
१.९३ करोड
Volume
१७.२८ हजार
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ ०.८०
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
News stories
From web sources and news partners
Quantisnow
·
२३ मिनेट पहिले
Vipshop to Announce Third Quarter 2026 Financial Results on November 24, 2026
StreetInsider
·
१८ मिनेट पहिले
Global S&P Futures mixed to lower in premarket
MarketWatch
·
२ घण्टा पहिले
Why this 40-year market veteran is making a lonely bet on a 40% stock-market crash — and $500 oil
Business Insider
·
१६ मिनेट पहिले
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc